All Home Care Matters Takes Over Leadership Role of AlzAuthors

March 7, 2026 6:20 AM

All Home Care Matters, the nation's leading caregiver-focused media platform, resource and voice in long-term care that continues to expand its reach, impact and influence around the world, began 2026 by announcing plans to take over the leadership role of AlzAuthors, the leading community of authors writing about Alzheimer's and dementia. Lance A. Slatton widely known as "The Senior Care Influencer" and founder of All Home Care Matters, and...

Read more

Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories

March 7, 2026 6:15 AM

Dipylon Medical, a specialized provider of laboratory and diagnostic technologies, today announced the expansion of its portfolio of clinical microbiology and molecular diagnostic equipment, supporting laboratories, hospitals, and research institutions with advanced tools for infectious disease detection and biomedical research. The expansion reflects growing global demand for molecular diagnostics, microbiology testing, and automated...

Read more

HIMSS26 Must-See: Follow the Trophies to 70 Black Book Top Client-Rated Vendors

March 6, 2026 2:10 PM

Black Book is urging HIMSS26 attendees to make time for over seventy Top Client-Rated Vendors recognized for exceptional user satisfaction by healthcare clients so far in 2026. For easier identification on the show floor, attendees should also look for honoree booths displaying Black Book trophies onsite.With HIMSS26 taking place March 9-12, 2026, at the Venetian Convention & Expo Center in Las Vegas, these recognized exhibitors represent...

Read more

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry's Reckoning Is Coming

March 6, 2026 1:47 PM

For the past several years, a growing segment of the cannabis industry has chased what many executives believed was the fastest route to profit: hemp-derived THC beverages, gummies, and intoxicating cannabinoid products sold under the Agriculture Improvement Act of 2018 loophole. The business model looked irresistible.Companies could manufacture intoxicating cannabinoid products derived from hemp, place them in convenience stores, liquor...

Read more

Buckingham Center for Facial Plastic Surgery Announces 2026 Castle Connolly Honors

March 6, 2026 12:15 PM

Buckingham Center for Facial Plastic Surgery is proud to announce national recognition for the 3 double-board certified facial plastic surgeons through Castle Connolly's 2026 distinctions. Dr. Edward Buckingham and Dr. Erin Smith have been named Castle Connolly Top Doctors, and Dr. Hudson Frey has been honored as a Castle Connolly Rising Star.These peer-nominated recognitions reflect a standard of excellence grounded in clinical mastery,...

Read more

CVS Health: Strengthening Health Through Housing

March 6, 2026 8:30 AM

Originally published on CVS Health Company NewsAt CVS Health® we know that housing is health care. That's why we've invested $2.1 billion to create, preserve and renovate 118,000 affordable housing units in more than 1,400 neighborhoods nationwide. By addressing social determinants of health and providing families with safe, stable homes, we're making it possible for thousands of people to succeed in life. Keli Savage, AVP of Impact Investment...

Read more

Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026

March 5, 2026 4:00 PM

Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the third quarter ended January 31, 2026, on Thursday, March 12, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code...

Read more

12th Annual World Patient Safety Summit Marks Resounding Success in Global Push Toward Zero Preventable Harm

March 5, 2026 12:55 PM

The Patient Safety Movement Foundation (PSMF) successfully concluded its 12th Annual World Patient Safety, Science & Technology Summit on Friday February 27th, 2026 at the Laguna Cliffs Marriott Resort & Spa, bringing together global leaders committed to eliminating preventable patient harm.Centered on this year's theme, "The Power to Propel Change," the Summit united patients and families, frontline clinicians, hospital executives,...

Read more

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

March 5, 2026 12:20 PM

Most headlines about cannabis policy focus on legalization, tax revenue, or retail sales. But beneath the surface, a far more consequential battle has been unfolding inside the federal regulatory system-one that could ultimately determine who controls the future of cannabinoid medicine in the United States. At the center of that battle is MMJ International Holdings and its subsidiary MMJ BioPharma Cultivation.While thousands of companies built...

Read more

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target

March 5, 2026 11:05 AM

Emerging Growth Research today released a Flash Research Update on Immuron Limited (Nasdaq:IMRN), maintaining its Buy-Extended rating and 12-month price target of $3.90 following the Company's release of first-half fiscal year 2026 financial results and strategic update.The Flash Report notes that Immuron reported global product revenue of AUD $4.18 million for the six months ended December 31, 2025, representing approximately 5% growth compared...

Read more

Rare Stan Lee-Signed Marvel Paintings by Rob Prior Lead High-Stakes Bidding in Infinite Auctions Event

March 5, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that the highly anticipated "Legends Art Auction", hosted by its subsidiary Infinite Auctions www.infiniteauctions.com, is entering its final days with strong bidding activity ahead of the auction's close on Saturday, March 7 at 6:00 PM Eastern Time.The auction features a remarkable collection of celebrity, sports, and pop culture artwork highlighted by internationally acclaimed...

Read more

Dermata Opens a New Chapter with the Release of Tome Skincare

March 5, 2026 9:00 AM

Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today proudly announces the branding of its latest innovation in skincare: Tome, which aims to introduce "skintech at home". The Company's Tome skincare line will bring intentionally developed skincare that delivers a high level of efficacy by addressing the root causes of skin diseases and conditions. Tome is...

Read more

TRNR Updates FAQ'S Following Full Loan Recovery and Successful Legal Settlement with Sportstech

March 5, 2026 9:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, and pending acquirer or Ergatta, today announced it had updated its FAQs in connection with its full loan recovery and successful legal settlement with Sportstech. The Company urges all shareholders to review the information and updates carefully.TRNR Investor...

Read more

Glidewell Enhances Glidewell Signature(TM) Service

March 5, 2026 9:00 AM

Glidewell is enhancing Glidewell Signature™, the fully digital, guided service designed to bring predictability to restorative dentistry using dental photography, simulated smile designs and digital communications. Glidewell Signature is built as a flexible framework to support a wide range of restorative workflows. The service provides step-by-step support for dentists from case planning to final delivery providing dentists with predictable...

Read more

CVS Specialty Delivers Enhanced Patient Experiences, Studies Show

March 5, 2026 9:00 AM

Three recent studies showcase how our CVS Specialty care models are uniquely positioned to meet patients' needs.Patients in a CVS Specialty pharmacist-managed program showed significantly higher medication adherence rates.We're meeting patients with rare diseases where they are -including in rural and underserved populations.Patient-reported data helps us understand teduglutide therapy's impact on lifestyle.Originally published on CVS...

Read more

Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

March 5, 2026 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has completed its evaluation process to select the most suitable blockchain platforms on which to build smart contracts-enabled pharmaceutical...

Read more

Genflow Biosciences PLC Announces Issue of Equity & PDMR Notifications

March 5, 2026 7:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European-based biotechnology company focused on the development of gene therapies for age-related diseases, announces that it has raised £800,000 (the "Subscription") by way of an issue of 42,105,263 new ordinary shares of £0.0003 each ("Ordinary Shares") at a price of 1.9p per new Ordinary Share (the "Issue Price") by way of subscriptions ("Subscription Shares"),...

Read more

Cantargia to Participate at Van Lanschot Kempen's Life Sciences Conference

March 5, 2026 4:20 AM

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) today announced that members of Cantargias management will participate in one-on-one meetings at the Van Lanschot Kempen Life Sciences Conference in Amsterdam on Thursday, April 16, 2026.For further information, please contactHilde Steineger, CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected] CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company...

Read more

Viemed Healthcare Announces 2026 Share Repurchase Program

March 4, 2026 4:45 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027.Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131...

Read more

Viemed Healthcare Announces Record 2025 Financial Results

March 4, 2026 4:45 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months and year ended December 31, 2025, and issued its guidance for the full year ending December 31, 2026.Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD):Net revenues...

Read more